BRUSSELS (AP) — The European Union cemented its support for Pfizer-BioNTech and its novel COVID-19 vaccine technology Saturday by agreeing to a massive contract extension for a potential 1.8 billion doses through 2023.
EU Commission President Ursula von der Leyen tweeted that her office “has just approved a contract for a guaranteed 900 million doses (+900 million options)."